Dr. Maninder Singh Guram, MD

Dr. Guram practices at Alpha Surgical Center in Tomball, Texas.

Dr. Guram's NPI, 1689671307, was assigned on July 7, 2005. Dr. Guram graduated from Government Medical College Amritsar in 1980. Dr. Guram holds Texas license J0511.

Dr. Guram's primary practice is Alpha Surgical Center, at 24727 Tomball Surgical Center, Tomball, TX 77375. The practice phone is (346) 336-7800.

Dr. Guram's primary practice is Alpha Surgical Center in Tomball, Texas. Dr. Guram is also affiliated with HCA Houston Healthcare Tomball. The medical group on file is OBGYN Medical Center Associates. Dmand AI also links Dr. Guram to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guram practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Guram's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Guram is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Guram's licenses on file in 4 states: Texas, New Jersey, South Carolina and Illinois.

Dmand AI lists acid reflux, cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and intestinal diverticulosis among the conditions Dr. Guram treats.

CMS data shows 71,242 Medicare services from Dr. Guram across 15 procedure codes in 2024, for 389 Medicare patients. Medicare paid $204,153 for them.

CMS counts 389 Medicare patients who saw Dr. Guram in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guram's median patient age at 64, with 46% women.

In 2024, Dr. Guram wrote 1,752 Medicare Part D claims for 489 patients. 79% of them were for generic drugs. CMS names the drug for 1,501 of them, across 23 drugs with 11 or more claims each, at $598,900 in total drug cost. In 2023, CMS named 1,524 claims across 26 drugs.

Dr. Guram accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 129 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Guram, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Guram. The most frequent topics are Cricetinae, Abnormalities, Drug-Induced and Chlordiazepoxide. Dr. Guram has published most often in Dig Dis Sci. Dr. Guram's most frequent co-author is Horst R. Konrad, MD.

Dmand AI links Dr. Guram to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Asthma, Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 108 general payments to Dr. Guram from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Covidien LP paid the most, $416.

Dr. Guram graduated from Government Medical College Amritsar in 1980. Dr. Guram is a member of ACP.

Dr. Guram is in network with 23 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.